---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-24-039083"
form_type: "8-K"
ticker: "IMCR"
cik: "0001671927"
company_name: "Immunocore Holdings plc"
filed_at: "2024-08-29T23:59:59+00:00"
generated_at: "2026-05-31T06:59:57.914274+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Immunocore CFO Brian Di Donato resigns, effective Dec 31, 2024, to become CEO at private biotech

## Summary
- CFO and Head of Strategy Brian Di Donato resigns effective Dec 31, 2024, to become CEO at a private early-stage biotech in San Diego.
- Resignation not due to any disagreement with Immunocore on financials, internal controls, or policies.
- Di Donato remains through year-end to ensure smooth transition; formal CFO search initiated.
- Di Donato joined over 4 years ago, led IPO and built Finance department.

## SEC filing metadata
- accession: 0001140361-24-039083
- form_type: 8-K
- ticker: IMCR
- cik: 0001671927
- company_name: Immunocore Holdings plc
- filed_at: 2024-08-29T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1671927/000114036124039083/0001140361-24-039083-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1671927/000114036124039083/ef20035097_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-24-039083
- JSON: https://secwatch.observer/filing/0001140361-24-039083.json
- Plain text: https://secwatch.observer/filing/0001140361-24-039083.txt

## Key facts
- Executive change
  Brian Di Donato resigned as Chief Financial Officer at Immunocore Holdings plc.
  - Action: resigned
  - Role: Chief Financial Officer
  source text: Mr. Brian Di Donato notified Immunocore Holdings plc (the “Company”) of his decision to resign as Executive Vice President, Chief Financial Officer and Head of Strategy and principal financial officer of the Company, effective December 31, 2024, to pursue another opportunity.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1671927/000114036124039083/0001140361-24-039083-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.